Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease

被引：46

作者：

Friese, G ^{[1
]}

Discher, T

Füssle, R

Schmalreck, A

Lohmeyer, J

机构：

[1] Univ Hosp Giessen, Dept Internal Med, Giessen, Germany

[2] Univ Hosp Giessen, Dept Microbiol, Giessen, Germany

[3] Heinrich Mack GmbH, Pfizer Grp, Microbiol Unit, Illertissen, Germany

来源：

AIDS | 2001年 / 15卷 / 17期

关键词：

D O I：

10.1097/00002030-200111230-00026

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：2344 / 2345

页数：2

共 5 条

[1] The hidden danger of primary fluconazole prophylaxis for patients with AIDS [J].

Berg, J ;

Clancy, CJ ;

Nguyen, MH .

CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :186-187

[2] Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus - Associated cryptococcosis [J].

Brandt, ME ;

Pfaller, MA ;

Hajjeh, RA ;

Graviss, EA ;

Rees, J ;

Spitzer, ED ;

Pinner, RW ;

Mayer, LW ;

Stephens, D ;

Farley, M ;

Rimland, D ;

Baughman, W ;

Lao, C ;

Otte, J ;

Harvey, C ;

Hamill, R ;

Reingold, AL ;

Rothrock, G ;

Pattni, B ;

Daily, P .

JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04) :812-820

[3] Role of fluconazole in the management of AIDS-related cryptococcosis, according to daily dosing [J].

Manfredi, R ;

Chiodo, F .

CHEMOTHERAPY, 1998, 44 (03) :206-214

[4] CRYPTOCOCCAL MENINGITIS AND AIDS [J].

POWDERLY, WG .

CLINICAL INFECTIOUS DISEASES, 1993, 17 (05) :837-842

[5]

POWDERLY WG, 1996, CLIN INF DIS SS, V22, P119

← 1 →